Two Approaches for Measuring Treatment Value Under Uncertainty:
Estimating Insurance Value and Risk Preferences in Neurology

ENPřihlásit se Přihlásit se (EduID)

Two Approaches for Measuring Treatment Value Under Uncertainty: Estimating Insurance Value and Risk ...

Přehled o publikaci

J 2025

Two Approaches for Measuring Treatment Value Under Uncertainty: Estimating Insurance Value and Risk Preferences in Neurology

SHAFRIN, Jason; Kyi-Sin THAN; Jacob FAJNOR; Jaehong KIM; Elizabeth S. MEARNS et. al.

Základní údaje

Originální název

Two Approaches for Measuring Treatment Value Under Uncertainty: Estimating Insurance Value and Risk Preferences in Neurology

Autoři

SHAFRIN, Jason; Kyi-Sin THAN; Jacob FAJNOR; Jaehong KIM; Elizabeth S. MEARNS; Stacey L. KOWAL; Thomas MAJDA a Jakub HLÁVKA

Vydání

Policy, Germany, De Gruyter, 2025, 2194-6191

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Stát vydavatele

Německo

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Organizace

Ekonomicko-správní fakulta – Masarykova univerzita – Repozitář

DOI

https://doi.org/10.1515/fhep-2024-0038

EID Scopus

2-s2.0-105010968030

Klíčová slova anglicky

neurology; insurance value; broader value elements; health-related quality of life

Změněno: 4. 11. 2025 00:50, RNDr. Daniel Jakubík

Anotace

V originále

Neurological conditions adversely impact patients and society due to both quality-of-life decrements and high financial burden. Traditional cost effectiveness methods, however, may undervalue neurological treatments by assuming patients are risk neutral. This study seeks first to quantify insurance value for hypothetical treatments that delay the (i) cognitive and (ii) physical impairments of neurological conditions. Moreover, this study also measures risk preferences over neurological health states to inform parameterization of generalized risk-adjusted cost effectiveness (GRACE) analyses.

Přiložené soubory

https://is.muni.cz/publication/2513619/Two_Approaches_for_Measuring_Treatment_Value_Under_Uncertainty_Hlavka_2025.pdf

Citovat

SHAFRIN, Jason; Kyi-Sin THAN; Jacob FAJNOR; Jaehong KIM; Elizabeth S. MEARNS; Stacey L. KOWAL; Thomas MAJDA a Jakub HLÁVKA. Two Approaches for Measuring Treatment Value Under Uncertainty: Estimating Insurance Value and Risk Preferences in Neurology. Policy. Germany: De Gruyter, 2025. ISSN 2194-6191. Dostupné z: https://doi.org/10.1515/fhep-2024-0038.

@article{88348,
   author = {Shafrin, Jason and Than, KyiandSin and Fajnor, Jacob and Kim, Jaehong and Mearns, Elizabeth S. and Kowal, Stacey L. and Majda, Thomas and Hlávka, Jakub},
   article_location = {Germany},
   doi = {https://doi.org/10.1515/fhep-2024-0038},
   keywords = {neurology; insurance value; broader value elements; health-related quality of life},
   language = {eng},
   issn = {2194-6191},
   journal = {Policy},
   title = {Two Approaches for Measuring Treatment Value Under Uncertainty: Estimating Insurance Value and Risk Preferences in Neurology},
   url = {https://www.degruyterbrill.com/document/doi/10.1515/fhep-2024-0038/html?recommended=sidebar},
   year = {2025}
}

TY  - JOUR
ID  - 88348
AU  - Shafrin, Jason - Than, Kyi-Sin - Fajnor, Jacob - Kim, Jaehong - Mearns, Elizabeth S. - Kowal, Stacey L. - Majda, Thomas - Hlávka, Jakub
PY  - 2025
TI  - Two Approaches for Measuring Treatment Value Under Uncertainty: Estimating Insurance Value and Risk Preferences in Neurology
JF  - Policy
PB  - De Gruyter
SN  - 2194-6191
KW  - neurology
KW  - insurance value
KW  - broader value elements
KW  - health-related quality of life
UR  - https://www.degruyterbrill.com/document/doi/10.1515/fhep-2024-0038/html?recommended=sidebar
N2  - Neurological conditions adversely impact patients and society due to both quality-of-life decrements and high financial burden. Traditional cost effectiveness methods, however, may undervalue neurological treatments by assuming patients are risk neutral. This study seeks first to quantify insurance value for hypothetical treatments that delay the (i) cognitive and (ii) physical impairments of neurological conditions. Moreover, this study also measures risk preferences over neurological health states to inform parameterization of generalized risk-adjusted cost effectiveness (GRACE) analyses.
ER  -

SHAFRIN, Jason; Kyi-Sin THAN; Jacob FAJNOR; Jaehong KIM; Elizabeth S. MEARNS; Stacey L. KOWAL; Thomas MAJDA a Jakub HLÁVKA. Two Approaches for Measuring Treatment Value Under Uncertainty: Estimating Insurance Value and Risk Preferences in Neurology. \textit{Policy}. Germany: De Gruyter, 2025. ISSN~2194-6191. Dostupné z: https://doi.org/10.1515/fhep-2024-0038.